Trending

SteadyNo clear rise or fall over the last three months.

Weight-loss drugs

Last 3 months vs 3 before

-15%

vs same 3 months last year

-40%

Next 3 months, likely

-35% to +7%

Our stories this week

2

Weekly views of “Semaglutide” (31%), “Tirzepatide” (27%), “Retatrutide” (27%), “GLP-1 receptor agonist” (14%) on English Wikipedia, people only, from Wikimedia; the share is each article’s part of the last three months. The dashed line carries the last six months’ growth forward; the band is the middle 60% of how far off that was over the past year, across every category. Checked on 1,008 past quarters: the trend line was typically 22% off, and assuming nothing changes was 18% off, so the plain guess did as well or better: read the range, not the line. How categories work